Cuirong Xu^1,*, Han Yan², Dawei Xu³, Guanjie Chen⁵, Qian Xu², Kunpeng Li⁶, Yehao Rui⁷, Zanmin Song³, Neeraj Gill³, Jing Sun^3,4,*

International Journal of Mental Health Promotion, Vol.25, No.10, pp. 1089-1102, 2023, DOI:10.32604/ijmhp.2023.030526 - 03 November 2023

Abstract Objective: The purpose of this study was to evaluate the effectiveness of post-traumatic growth (PTG) model-based intervention to improve positive psychological traits in Chinese breast cancer patients. Design: A randomized control trial of a psychological group intervention based on PTG model. Methods: The Clinical Trial was registered on 17 August 2019 at Chinese Clinical Trials.gov with Registration number ChiCTR1900025264. A total of 92 patients with breast cancer were recruited. The participants were randomly assigned to the experimental group (n = 46) and the control group (n = 46). A six-session psychological group intervention based on PTG model… More >

Yue Yuan^1,*, Aibao Zhou^1,*, Tinghao Tang¹, Manying Kang², Haiyan Zhao¹, Zhi Wang³

International Journal of Mental Health Promotion, Vol.25, No.4, pp. 563-577, 2023, DOI:10.32604/ijmhp.2023.022161 - 01 March 2023

Abstract Objective: In this research, we tried to explore how short-term mindfulness (STM) intervention affects adolescents’ anxiety, depression, and negative and positive emotion during the COVID-19 pandemic. Design: 10 classes were divided into experiment groups (5 classes; n = 238) and control (5 classes; n = 244) randomly. Hospital Anxiety and Depression Scale (HADS) and Positive and Negative Affect Schedule (PANAS) were used to measure participants’ dependent variables. In the experiment group, we conducted STM practice interventions every morning in their first class from March to November 2020. No interventions were conducted in the control group. Methods: Paired-sample t-tests were used to identify… More >

Aibao Zhou¹, Yue Yuan^1,*, Manying Kang²

International Journal of Mental Health Promotion, Vol.24, No.5, pp. 665-677, 2022, DOI:10.32604/ijmhp.2022.019623 - 27 July 2022

Abstract Background: Since the outbreak of COVID-19 caused adults suffer from mental disorders, it would be an essential for psychologist to help individuals overcome mental disorders. Objective: This study aim to explore whether the intervention of mindfulness is an efficient method to enhance adolescents’ emotional intelligence (EI) and psychological capital (PC) to provide a theoretical basis and future directions for both targeted crisis intervention and psychological trauma recovery plans. Design: This research was designed as randomized controlled trial and total of 798 students were evaluated statistically. Methods: We used paired-sample t-tests and repeated measures ANOVA to compare every factor defined… More >

Heming Lu^*†1, Yuying Wu^‡1, Xu Liu^†, Huixian Huang^†, Hailan Jiang^†, Chaohua Zhu^†, Yuping Man^§, Zhaohong Chen^†, Xianfeng Long^†, Qiang Pang^†, Luxing Peng^†, Xianglong Li^†, Junzhao Gu^†, Shan Deng^†, Ligang Xing^*

Oncology Research, Vol.28, No.9, pp. 929-944, 2020, DOI:10.3727/096504021X16318716607908

Abstract This phase II randomized clinical trial aimed to assess the efficacy and toxicity of Endostar, an antiangiogenesis inhibitor, combined with concurrent chemoradiotherapy (CCRT) for locally advanced cervical cancer (LACC). Patients with LACC were randomly assigned to either CCRT plus Endostar (CCRT+E arm) or CCRT alone (CCRT arm). All patients received pelvic intensity-modulated radiation therapy (IMRT) and brachytherapy. Weekly cisplatin was administered concurrently with IMRT. Patients in the CCRT+E arm also received concurrent Endostar every 3 weeks for two cycles. The primary endpoint was progression-free survival (PFS) and acute toxicities. The exploratory endpoint was the impact… More >

Chunmou Li^*1, Xiaomin Peng^*1, Chuchu Feng^*1, Xilin Xiong^*, Jianxin Li^†, Ning Liao^‡, Zhen Yang^§, Aiguo Liu^¶, Pingping Wu^*, Xuehong Liang^†, Yunyan He^‡, Xin Tian^§, Yunbi Lin^§, Songmi Wang^¶, Yang Li^*

Oncology Research, Vol.28, No.7-8, pp. 791-800, 2020, DOI:10.3727/096504021X16184815905096

Abstract This nonrandomized, multicenter cohort, open-label clinical trial evaluated the efficacy and safety of combined chemotherapy with arsenic trioxide (ATO) in children with stage 4/M neuroblastoma (NB). We enrolled patients who were newly diagnosed with NB and assessed as stage 4/M and received either traditional chemotherapy or ATO combined with chemotherapy according to their own wishes. Twenty-two patients were enrolled in the trial group (ATO combined with chemotherapy), and 13 patients were enrolled in the control group (traditional chemotherapy). Objective response rate (ORR) at 4 weeks after completing induction chemotherapy was defined as the main outcome,… More >

Chunping Lu^1,#, Liye Zou^2,#, Benjamin Becker³, Mark D. Griffiths⁴, Qian Yu², Si-Tong Chen⁵, Zsolt Demetrovics⁶, Can Jiao⁷, Xinli Chi⁷, Aiguo Chen⁸, Albert Yeung⁹, Shijie Liu¹⁰, Yanjie Zhang^2,11,*

International Journal of Mental Health Promotion, Vol.22, No.4, pp. 271-282, 2020, DOI:10.32604/IJMHP.2020.014419 - 22 December 2020

Abstract Purpose: The purpose of the present study was to compare the effectiveness of mind-body exercise (ME) and cognitive behavioral therapy (CBT) on addiction level and psychological well-being among college students with problematic smartphone use (PSU). Methods: A 12-week randomized controlled study was carried out at a university in central China. A total of 95 PSU college students who met the inclusion criteria were randomly assigned to a ME group (ME, n = 31), CBT group (CBT, n = 30), or control group (CG, n = 34). Both ME intervention and CBT, twice per week for 90… More >

Guanling Chen¹, Zhaoze Guo¹, Minfeng Liu, Guangyu Yao, Jianyu Dong, Jingyun Guo, Changsheng Ye

Oncology Research, Vol.25, No.9, pp. 1567-1578, 2017, DOI:10.3727/096504017X14897173032733

Abstract Capecitabine has consistently demonstrated high efficacy and acceptable tolerability in salvage chemotherapy for advanced breast cancer. However, there remains no consensus on its role in adjuvant chemotherapy for early breast cancer (EBC). To estimate the value of capecitabine-based combination adjuvant treatment in EBC, eight randomized controlled trials with 14,072 participants were analyzed. The efficacy and safety outcomes included disease-free survival (DFS), overall survival (OS), relapse, breast cancer-specific survival (BCSS), and grades 3–5 adverse events. Capecitabine-based combination adjuvant chemotherapy demonstrated a 16% increase in BCSS (HR = 0.84, 95% CI = 0.71–0.98, p = 0.03) in the… More >